Efficacy assessment of a triple anthrax chimeric antigen as a vaccine candidate in guinea pigs: challenge test with Bacillus anthracis 17 JB strain spores.

Masoud Abdous Sadegh Hasannia Ali-Hatef Salmanian Seyed-Shahryar Arab

Published in: Immunopharmacology and immunotoxicology (2021)

It is concluded that the ELP antigen has the necessary requirement for proper immunization against anthrax and it can be used to develop an effective recombinant vaccine candidate against anthrax.

Keyphrases

cell therapy
bacillus subtilis
bone marrow